BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16049315)

  • 1. Bone marrow engraftment analysis after granulocyte transfusion.
    Swierczynski SL; Hafez MJ; Philips J; Higman MA; Berg KD; Murphy KM
    J Mol Diagn; 2005 Aug; 7(3):422-6. PubMed ID: 16049315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of bone marrow engraftment by amplification of hypervariable DNA regions.
    Martinelli G; Trabetti E; Farabegoli P; Testoni N; Bandini G; Motta MR; Vittone A; Terragna C; Pignatti PF; Tura S
    Haematologica; 1997; 82(2):156-60. PubMed ID: 9175318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplant engraftment analysis with loss of an informative allele.
    Schichman SA; Lin P; Gilbrech LJ; Gray PS; Wilson CS; Sawyer JR
    J Mol Diagn; 2002 Nov; 4(4):230-2. PubMed ID: 12411591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
    Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
    Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of short tandem repeat and variable number tandem repeat genetic markers for quantitative determination of allogeneic bone marrow transplant engraftment.
    Schichman SA; Suess P; Vertino AM; Gray PS
    Bone Marrow Transplant; 2002 Feb; 29(3):243-8. PubMed ID: 11859397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte transfusion as a treatment for enterococcal meningoencephalitis after allogeneic bone marrow transplantation from an unrelated donor.
    Tsukada Y; Nagayama H; Mori T; Shimizu T; Sato N; Takayama N; Ishida A; Handa M; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2003 Jan; 31(1):69-72. PubMed ID: 12621511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study.
    Choi SJ; Lee JH; Lee JH; Kim S; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Jang S; Park CJ; Chi HS; Lee KH
    Bone Marrow Transplant; 2005 Jul; 36(2):163-9. PubMed ID: 15937507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
    Azuno Y; Kaneko T; Nishimura M; Okuya S; Nakai K; Nomiyama J; Mori K; Okafuji K; Okubo M; Matsutani A; Kamei S; Zaitsu Y; Takeuchi Y; Oka Y; Kaku K
    Bone Marrow Transplant; 1996 Jul; 18(1):257-9. PubMed ID: 8832032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.
    Kessinger A; Smith DM; Strandjord SE; Landmark JD; Dooley DC; Law P; Coccia PF; Warkentin PI; Weisenburger DD; Armitage JO
    Bone Marrow Transplant; 1989 Nov; 4(6):643-6. PubMed ID: 2573397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of short tandem repeats with fluorescence labeling polymerase chain reaction to document engraftment following allogeneic bone marrow transplantation].
    Xiao L; Guo K; Chen H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):418-22. PubMed ID: 11718093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allogeneic bone marrow transplantation in proliferative blood diseases in children and adolescents (preliminary observations)].
    Wachowiak J; Kaczmarek-Kanold M; Radwańska U; Wojtalik M
    Acta Haematol Pol; 1991; 22(2):310-7. PubMed ID: 1841503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an automated technique for assessment of marrow engraftment after allogeneic bone marrow transplantation using a commercially available kit.
    Nuckols JD; Rasheed BK; McGlennen RC; Bigner SH; Stenzel TT
    Am J Clin Pathol; 2000 Jan; 113(1):135-40. PubMed ID: 10631867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA typing for bone marrow engraftment follow-up after allogeneic transplant: a comparative study of current technologies.
    Leclair B; Frégeau CJ; Aye MT; Fourney RM
    Bone Marrow Transplant; 1995 Jul; 16(1):43-55. PubMed ID: 7581128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
    Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
    Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of engraftment after repeated autologous bone marrow transplantation.
    van Besien K; Nichols CR; Tricot G; Langefeld C; Miller ME; Akard L; English DK; Graves VL; Cheerva A; McCarthy LJ
    Exp Hematol; 1990 Aug; 18(7):785-8. PubMed ID: 2165911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.
    Madero L; Díaz MA; Ortega JJ; Olive T; Martínez A; Badell I; Muñoz A; Gómez P
    Haematologica; 1999 Feb; 84(2):133-7. PubMed ID: 10091411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of granulocyte colony-stimulating factor in patients after allogeneic bone marrow transplantation for chronic myeloid leukemia correlate with engraftment of transplanted marrow.
    Busch FW; Pilgrim TB; Krämer A; Ehninger G
    Bone Marrow Transplant; 1997 Apr; 19(7):653-9. PubMed ID: 9156241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.